Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 205 resources
-
Drug-related infectious diseases in Europe
This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.UK, Rest of World 16 Jul 2019 Reports & Research PDF -
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.Rest of World 09 Jul 2019 Reports & Research PDF -
Information for GPs on the Infected Blood Inquiry
This document from Public Health England provides information for GPs on the ongoing Infected Blood Inquiry, chaired by Sir Brian Langstaff. The document covers: why there is an Infected Blood Inquiry; what to advise if your patient thinks that they received blood in the 1970s/1980s; what to do if your patient is hepatitis C positive and is concerned a past transfusionUK 05 Jul 2019 Training, Reports & Research PDF -
WHO progress report on HIV, viral hepatitis and STIs 2019
The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.Rest of World Reports & Research, Strategy & Planning PDF -
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.UK, Rest of World Reports & Research, Tools & Templates, Strategy & Planning PDF -
Hepatitis C in England 2019 report
Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C Annual Epidemiological Report for 2017
The European Centre for Disease Prevention and Control has published a new report on the prevalence of hepatitis C in Europe. The report indicates a 10% decrease in newly reported hepatitis C cases from 2016 to 2017, but also warns of the under-reporting of diagnosed cases and the variation of national testing practices impacting the reliability of this statistic. Headline figures show that 5.6 million Europeans live with chronic hepatitis C, with more than 31,000 recorded cases in 2017.Rest of World Reports & Research PDF -
Evalution of injecting equipment providing services in NHS Tayside
The Scottish Drugs Forum and Hepatitis Scotland carried out an evaluation of the effectiveness of injecting equipment providing services, noting barriers and recommendations to Tayside NHS. The report includes information on the provision of hepatitis C testing at injecting equipment providing services.UK, Scotland Reports & Research PDF -
Hepatitis C Coalition Roundtable on HCV and Blood Borne Viruses in Prison
This report summarises a December 2018 meeting organised by the Hepatitis C Coalition to discuss hepatitis C and BBVs in prison. The report covers discussion points including the need for better implementation of opt-out testing, reducing points of attrition along the care pathway, tackling stigma and developing stronger links with community services.England 06 Feb 2019 Reports & Research, Strategy & Planning PDF -
Scotland: Report of the National Short Life Working Group (SLWG) on Hepatitis C Virus Case Finding and Access to Care
Following a request by the Scottish Government, a short life working group (SLWG) was convened and commissioned to develop recommendations on improvements in case-finding and treatment for hepatitis C in Scotland. The remit of the group was to review evidence and agree recommendations on four key topic areas: awareness-raising, case-finding, novel approaches to testing, and access to care. This report describes the methodology, key findings, and recommendations of the SLWG.Scotland Reports & Research PDF